A Dark Vector Cognition product

Item 1A. RISK FACTORS

3K characters. Original on sec.gov · Markdown

Item 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially affect our business, financial condition and results of operations. There have been no material changes to the risk factors described in the “Risk Factors” section in our Annual Report on Form 10-K for the year ended December 31, 2025. The risks described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition and results of operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table presents our share repurchases made pursuant to our share repurchase program for the three months ended March 31, 2026:

Total Number of Shares Purchased (1)Average Price per ShareTotal Number of Shares Purchased as Part of a Publicly Announced Program (1)Approximate Dollar Value That May Yet Be Purchased Under the Program (in millions)
Period
January 1 - 31, 202611,109$129.8011,109$349.0
February 1 - 28, 2026—$——$349.0
March 1 - 31, 2026—$——$349.0
Total11,109$129.8011,109
(1) In November 2023, our board of directors authorized a three-year share repurchase program allowing the repurchase of shares with an aggregate value up to $500.0 million of common stock. Purchases are made at management’s discretion based on market conditions and financial resources. As of March 31, 2026, we had remaining authorization to repurchase shares with an aggregate value up to $349.0 million.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION